IOB - Delayed Quote SEK

Getinge AB (publ) (0GZV.IL)

Compare
218.80
-0.60
(-0.27%)
At close: 4:49:22 PM GMT
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
34,759,000.00
34,759,000.00
31,827,000.00
28,291,000.00
27,049,000.00
Cost of Revenue
18,606,000.00
18,606,000.00
17,332,000.00
14,882,000.00
13,469,000.00
Gross Profit
16,153,000.00
16,153,000.00
14,495,000.00
13,410,000.00
13,580,000.00
Operating Expense
12,400,000.00
12,400,000.00
10,517,000.00
9,534,000.00
9,232,000.00
Operating Income
3,753,000.00
3,753,000.00
3,978,000.00
3,876,000.00
4,348,000.00
Net Non Operating Interest Income Expense
-571,000.00
-571,000.00
-393,000.00
-174,000.00
-183,000.00
Pretax Income
2,282,000.00
2,282,000.00
3,343,000.00
3,472,000.00
4,188,000.00
Tax Provision
628,000.00
628,000.00
915,000.00
956,000.00
1,187,000.00
Net Income Common Stockholders
1,638,000.00
1,638,000.00
2,412,000.00
2,491,000.00
2,970,000.00
Diluted NI Available to Com Stockholders
1,638,000.00
1,638,000.00
2,412,000.00
2,491,000.00
2,970,000.00
Basic EPS
6.01
--
8.86
9.15
10.90
Diluted EPS
6.01
--
8.86
9.15
10.90
Basic Average Shares
272,370.00
--
272,370.00
272,369.57
272,369.57
Diluted Average Shares
272,370.00
--
272,370.00
272,369.57
272,369.57
Total Operating Income as Reported
2,854,000.00
2,854,000.00
3,736,000.00
3,626,000.00
4,371,000.00
Total Expenses
31,006,000.00
31,006,000.00
27,849,000.00
24,416,000.00
22,701,000.00
Net Income from Continuing & Discontinued Operation
1,638,000.00
1,638,000.00
2,412,000.00
2,491,000.00
2,970,000.00
Normalized Income
2,288,872.92
2,288,872.92
2,587,763.09
2,656,300.00
3,038,790.83
Interest Income
--
--
123,000.00
54,000.00
10,000.00
Interest Expense
--
--
469,000.00
205,000.00
152,000.00
Net Interest Income
-571,000.00
-571,000.00
-393,000.00
-174,000.00
-183,000.00
EBIT
3,753,000.00
3,753,000.00
3,978,000.00
3,677,000.00
4,340,000.00
EBITDA
6,174,000.00
6,174,000.00
6,071,000.00
5,704,000.00
6,154,000.00
Reconciled Cost of Revenue
18,606,000.00
18,606,000.00
17,332,000.00
14,882,000.00
13,469,000.00
Reconciled Depreciation
2,421,000.00
2,421,000.00
2,093,000.00
2,027,000.00
1,814,000.00
Net Income from Continuing Operation Net Minority Interest
1,638,000.00
1,638,000.00
2,412,000.00
2,491,000.00
2,970,000.00
Total Unusual Items Excluding Goodwill
-898,000.00
-898,000.00
-242,000.00
-228,000.00
-96,000.00
Total Unusual Items
-898,000.00
-898,000.00
-242,000.00
-228,000.00
-96,000.00
Normalized EBITDA
7,072,000.00
7,072,000.00
6,313,000.00
5,932,000.00
6,250,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-247,127.08
-247,127.08
-66,236.91
-62,700.00
-27,209.17
12/31/2021 - 10/7/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MCAP.ST MedCap AB (publ)
367.00
+1.38%
 
PEXA-B.ST PExA AB
0.2130
0.00%
 
NEOLA.ST Neola Medical AB (publ)
2.5000
-2.34%
 
61MA.F MedCap AB (publ)
31.20
-1.27%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1284
-3.46%
 
CRAD-B.ST C-Rad AB (publ)
32.20
+0.63%
 
CLS-B.ST Clinical Laserthermia Systems AB (publ)
4.0200
+3.61%
 
CEVI.ST CellaVision AB (publ)
222.00
+3.74%
 
OSSD.ST OssDsign AB (publ)
10.04
-0.79%
 
XVIVO.ST Xvivo Perfusion AB (publ)
470.00
+2.62%